# The efficacy of the food-grade antimicrobial xanthorrhizol against Staphylococcus aureus is associated with McsL channel expression

**Authors:** Elena A. Mordukhova, Jongwan Kim, Haiyan Jin, Kyoung Tai No, Jae-Gu Pan

PMC · DOI: 10.3389/fmicb.2024.1439009 · 2024-07-03

## TL;DR

Xanthorrhizol, a natural compound, kills Staphylococcus aureus by targeting the McsL channel, showing potential as a new antimicrobial.

## Contribution

Xanthorrhizol's mechanism of action is linked to the McsL channel in S. aureus, offering a novel antimicrobial strategy.

## Key findings

- Xanthorrhizol reduces cell volume and causes cytoplasm efflux in S. aureus, suggesting McsL channel activation.
- S. aureus lacking McsL is more resistant to xanthorrhizol, confirming the channel's role in susceptibility.
- Xanthorrhizol enhances the effect of dihydrostreptomycin, an antibiotic that also targets McsL.

## Abstract

The emergence and spread of multidrug-resistant Staphylococcus aureus strains demonstrates the urgent need for new antimicrobials. Xanthorrhizol, a plant-derived sesquiterpenoid compound, has a rapid killing effect on methicillin-susceptible strains and methicillin-resistant strains of S. aureus achieving the complete killing of staphylococcal cells within 2 min using 64 μg/mL xanthorrhizol. However, the mechanism of its action is not yet fully understood.

The S. aureus cells treated with xanthorrhizol were studied using optical diffraction tomography. Activity of xanthorrhizol against the wild-type and mscL null mutant of S. aureus ATCC 29213 strain was evaluated in the time-kill assay. Molecular docking was conducted to predict the binding of xanthorrhizol to the SaMscL protein.

Xanthorrhizol treatment of S. aureus cells revealed a decrease in cell volume, dry weight, and refractive index (RI), indicating efflux of the cell cytoplasm, which is consistent with the spontaneous activation of the mechanosensitive MscL channel. S. aureus ATCC 29213ΔmscL was significantly more resistant to xanthorrhizol than was the wild-type strain. Xanthorrhizol had an enhanced inhibitory effect on the growth and viability of exponentially growing S. aureus ATCC 29213ΔmscL cells overexpressing the SaMscL protein and led to a noticeable decrease in their viability in the stationary growth phase. The amino acid residues F5, V14, M23, A79, and V84 were predicted to be the residues of the binding pocket for xanthorrhizol. We also showed that xanthorrhizol increased the efflux of solutes such as K+ and glutamate from S. aureus ATCC 29213ΔmscL cells overexpressing SaMscL. Xanthorrhizol enhanced the antibacterial activity of the antibiotic dihydrostreptomycin, which targets the MscL protein.

Our findings indicate that xanthorrhizol targets the SaMscL protein in S. aureus cells and may have important implications for the development of a safe antimicrobial agent.

## Linked entities

- **Genes:** mscL (large-conductance mechanosensitive channel) [NCBI Gene 881127]
- **Chemicals:** xanthorrhizol (PubChem CID 93135), dihydrostreptomycin (PubChem CID 439369)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** staphylococcal (MESH:D011023)
- **Chemicals:** K+ (MESH:D011188), methicillin (MESH:D008712), Xanthorrhizol (MESH:C120248), dihydrostreptomycin (MESH:D004096), sesquiterpenoid (MESH:D012717), glutamate (MESH:D018698)
- **Species:** Staphylococcus aureus (species) [taxon 1280]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11251944/full.md

---
Source: https://tomesphere.com/paper/PMC11251944